Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 72 citing articles:

Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
Vladimı́r Rudajev, Jiřı́ Novotný
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 43
Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Sakulrat Mankhong, Sujin Kim, Seongju Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 850-850
Open Access | Times Cited: 39
Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites
Karel Kalecký, Dwight C. German, Albert Montillo, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 4, pp. 1875-1895
Open Access | Times Cited: 38
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Haiyun Chen, Yuhan Zeng, Dan Wang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1478-1478
Open Access | Times Cited: 11
The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review
Xinyi Wang, Huaqiang Li, Yunjie Sheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116071-116071
Open Access | Times Cited: 10
Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 8
Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer’s disease
Auwal Abdullahi, Thomson W. L. Wong, Shamay S. M. Ng
Ageing Research Reviews (2024) Vol. 94, pp. 102202-102202
Closed Access | Times Cited: 7
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
Paola Gamba, Serena Giannelli, Erica Staurenghi, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 740-740
Open Access | Times Cited: 52
Circulating perturbation of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) is associated to cardiac remodeling and NLRP3 inflammasome in cardiovascular patients with insulin resistance risk
Elena Vianello, Federico Ambrogi, Marta Kalousová, et al.
Experimental and Molecular Pathology (2024) Vol. 137, pp. 104895-104895
Open Access | Times Cited: 6
Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease
Parisa Faraji, Hartmut Kühn, Shahin Ahmadian
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 3
Open Access | Times Cited: 5
Evolving concepts of low‐density lipoprotein: From structure to function
Chu‐Huang Chen, Tatsuya Sawamura, Alexander Akhmedov, et al.
European Journal of Clinical Investigation (2025)
Closed Access
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer
Nikola Odehnalová, Viera Šandriková, Róbert Hromádka, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Longitudinal association of hypertension and dyslipidemia with cognitive function in community-dwelling older adults: the SONIC study
Yuko Nakamura, Mai Kabayama, Kayo Godai, et al.
Hypertension Research (2023) Vol. 46, Iss. 8, pp. 1829-1839
Open Access | Times Cited: 15
Nonlinear relationship between triglycerides and cognitive function after acute ischemic stroke among older adults
Simin Cao, Liting Teng, Maofeng Gao, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27943-e27943
Open Access | Times Cited: 4
CPNE7 Regulates Amyloidogenesis Through CAP1‐Dependent ADAM10 Translation
Jie Yang, Yalan Pu, Qing Pan, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Open Access
Comparison of Deep Learning and Traditional Machine Learning Models for Predicting Mild Cognitive Impairment Using Plasma Proteomic Biomarkers
Kesheng Wang, Donald Adjeroh, Wei Fang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2428-2428
Open Access
Altered Mitochondrial Morphology and Bioenergetics in a New Yeast Model Expressing Aβ42
Khoren K. Epremyan, Anton G. Rogov, Tatyana N. Goleva, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 900-900
Open Access | Times Cited: 12
Lipids as Emerging Biomarkers in Neurodegenerative Diseases
Justin Wei, Li Chin Wong, Sebastian Boland
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 131-131
Open Access | Times Cited: 12
Identifying clinical features and blood biomarkers associated with mild cognitive impairment in Parkinson disease using machine learning
Xiao Deng, Yilin Ning, Seyed Ehsan Saffari, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 6, pp. 1658-1666
Closed Access | Times Cited: 10
Oxysterols: From redox bench to industry
Giuseppe Poli, Valerio Leoni, Fiorella Biasi, et al.
Redox Biology (2021) Vol. 49, pp. 102220-102220
Open Access | Times Cited: 26
Blood Lipid Biomarkers in Early Parkinson’s Disease and Parkinson’s Disease with Mild Cognitive Impairment
Xiao Deng, Seyed Ehsan Saffari, Samuel Yong Ern Ng, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 6, pp. 1937-1943
Closed Access | Times Cited: 18
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
Antía Custodia, Daniel Romaus‐Sanjurjo, Marta Aramburu-Núñez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8082-8082
Open Access | Times Cited: 16
Association between lipid metabolism and cognitive function in patients with schizophrenia
Huamin Liu, Zhiwei Huang, Xiaochun Zhang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 16
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
Xianfeng Yu, Kai Shao, Ke Wan, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 10
Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
Ruchika Bhawal, Qin Fu, Elizabeth T. Anderson, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13188-13188
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top